Pharmacogenetics is the area of medicine that looks at how the genetic makeup of an individual affects their response to drug treatment. Research studies have shown that genetics can explain much of the variability in patient response. In many of them, some drugs do not work as well as expected, while in other patients cause toxic effects even at lower doses, or otherwise not act in resolving the health problem. Much of the variation in drug efficacy and side effects has been shown to be associated with the genetic material of each individual. Significant changes have been identified, and evidence for many of them are now available in the clinical setting. With the knowledge of the genetic state of a patient and an adequate medical history, doctors can predict a patient’s response to medications and optimize treatment protocols. Adverse drug reactions can also be minimized because they have a substantial impact on mortality, morbidity and health care costs. This marks the beginning of the era of “personalized medicine” where drug combinations and doses are optimized for the unique genetic makeup of each individual.

The company Retrogen Inc. of the United States has delegated to our company its representation to various countries in Central and South America where we provide services in the following areas:

  • Cardiology
  • Pain Treatment
  • Psychiatry
  • Comprehensive Panel: Includes a combination of the above.

More information in or